Top Markets
Coin of the day
Diagnocure, Inc. Diagnocure, Inc.

Diagnocure, Inc.

DGCRF
Rang in Aktien #41419
Diagnocure, Inc. is a Canadian life sciences company dedicated to developing... Diagnocure, Inc. is a Canadian life sciences company dedicated to developing and commercializing innovative products for cancer diagnosis. Its core business revolves around advanced molecular diagnostic tests designed for the identification and management of cancerous conditions. The company's portfolio includes the PCA3 test for prostate cancer diagnosis, as well as the Guanylyl Cyclase C (GCC) marker and the Previstage GCC colorectal cancer staging test, both vital for patients with colorectal cancer. They also offer PCP, a multi-marker diagnostic for prostate cancer. In addition to these tests, Diagnocure provides specialized services such as gene expression and copy number variation analysis, mutation detection, SNP genotyping, and comprehensive platform and laboratory environmental support. Established in 1994 as 9342-8530 Québec Inc. and previously known as DiagnoCure Inc., the company is headquartered in Quebec, Canada.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2025-06-11
Marktkapitalisierung
$21.52K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
CA
Handel Diagnocure, Inc. (DGCRF)

Kategorie

Preis DGCRF mit Marktkapitalisierung von B
Diagnocure, Inc. Diagnocure, Inc.
DGCRF
$0.0001
Marktkapitalisierung von Diagnocure, Inc.(DGCRF)
Marktkapitalisierung: $21.52K
Mit Stand August 2026 hat Diagnocure, Inc. eine Marktkapitalisierung von $21.52K. Das macht Diagnocure, Inc. laut unseren Daten zum 41419th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Diagnocure, Inc. von 2012 bis 2026
DGCRF im Vergleich zu den Top 5 der beliebtesten stocks
Preis für DGCRF Vermögenswert B Marktkapitalisierung von B Ergebnisse
Diagnocure, Inc. Diagnocure, Inc.
$25,015.61 $21.52K
$5.383T +25,015,610,773.61%
Diagnocure, Inc. Diagnocure, Inc.
$20,554.79 $21.52K
$4.423T +20,554,791,738.93%
Diagnocure, Inc. Diagnocure, Inc.
$19,332.57 $21.52K
$4.160T +19,332,571,457.07%
Diagnocure, Inc. Diagnocure, Inc.
$17,022.87 $21.52K
$3.663T +17,022,866,242.94%
Diagnocure, Inc. Diagnocure, Inc.
$13,435.08 $21.52K
$2.891T +13,435,077,945.54%